| Electrolytes |
20010534 |
Ringer Lactate Baxter (пластмасови сакове и стъклени бутилки), Solution for infusion, Sodium Chloride 6 g/l, Sodium Lactate solution 50 % 6.34 g/l Potassium Chloride 0.4 g/l, Calcium Chloride dihydrate 0.27 g/l - 500 ml, ml, Pack: 20 |
Бакстер България ЕООД, България |
Bieffe Medital S.A., Spain; Bieffe Medital S.p.A., Italy; Baxter Healthcare Ltd., Caxton Way, Thretford, Norfolk IP24 3SE, Обединено кралство; Baxter S.A, Boulevard Rene Branquart 80, 7860 Lessines, Белгия |
30.78 |
6.16 |
36.94 |
4% |
1.23 |
32.01 |
6.4 |
38.41 |
16% |
4.92 |
36.93 |
7.39 |
44.32 |
промяна в обстоятелства НСР-5053/18.11.2014 |
КЦРР-1889/15.12.2012 г |
02.01.2013 |
02.01.2013 |
Неактивен |
1529 |
| Electrolytes |
ІІ-13012/17.05.2006 г. |
RINGER LACTATE SOLUTION, Solution for infusion, Sodium Chloride 6 g/l, Sodium Lactate solution 50 % 6.34 g/l Potassium Chloride 0.4 g/l, Calcium Chloride dihydrate 0.27 g/l - 500 ml, ml, Pack: 1 |
Fresenius Kabi Deutschland GmbH, Германия |
Fresenius Kabi Austria GmbH, Hafnerstrasse 36 A-8055 Graz, Austria; Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg v.d.H., Germany; Fresenius Kabi Italia SpA, Via Camagre, 41-43 I-37063 Isola Della Scala-Verona, Italy |
1.66 |
0.33 |
1.99 |
7% |
0.12 |
1.78 |
0.36 |
2.14 |
20% |
0.33 |
2.11 |
0.42 |
2.53 |
|
КЦ-929/28.05.2009; НСР-12066/21.03.2017 |
11.06.2009 |
02.05.2017 |
Заличен |
752 |
| Electrolytes |
ІІ-13012/17.05.2006 г. |
RINGER LACTATE SOLUTION, Solution for infusion, Sodium Chloride 6 g/l, Sodium Lactate solution 50 % 6.34 g/l Potassium Chloride 0.4 g/l, Calcium Chloride dihydrate 0.27 g/l - 500 ml, ml, Pack: 1 |
Fresenius Kabi Deutschland GmbH, Германия |
Fresenius Kabi Austria GmbH, Hafnerstrasse 36 A-8055 Graz, Austria; Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg v.d.H., Germany; Fresenius Kabi Italia SpA, Via Camagre, 41-43 I-37063 Isola Della Scala-Verona, Italy |
1.66 |
0.33 |
1.99 |
7% |
0.12 |
1.78 |
0.36 |
2.14 |
20% |
0.33 |
2.11 |
0.42 |
2.53 |
|
КЦ-929/28.05.2009 |
11.06.2009 |
11.06.2009 |
Неактивен |
752 |
| Electrolytes |
20030104 |
Ringer Lactatе Baxter, Solution for infusion, Sodium Chloride 6 g/l, Sodium Lactate solution 50 % 6.34 g/l Potassium Chloride 0.4 g/l, Calcium Chloride dihydrate 0.27 g/l - 1000 ml, ml, Pack: 10 |
Бакстер България ЕООД, България |
Bieffe Medital S.A., Spain; Bieffe Medital S.p.A., Italy; Baxter Healthcare Ltd., Caxton Way, Thretford, Norfolk IP24 3SE, Обединено кралство; Baxter S.A, Boulevard Rene Branquart 80, 7860 Lessines, Белгия |
19.75 |
3.95 |
23.7 |
6% |
1.19 |
20.94 |
4.19 |
25.13 |
18% |
3.56 |
24.5 |
4.9 |
29.4 |
|
НСР-5950/01.04.2015. |
16.04.2015 |
16.04.2015 |
Неактивен |
3784 |
| Electrolytes |
20030104 |
Ringer Lactatе Baxter, Solution for infusion, Sodium Chloride 6 g/l, Sodium Lactate solution 50 % 6.34 g/l Potassium Chloride 0.4 g/l, Calcium Chloride dihydrate 0.27 g/l - 1000 ml, ml, Pack: 10 |
Бакстер България ЕООД, България |
Bieffe Medital S.A., Spain; Bieffe Medital S.p.A., Italy; Baxter Healthcare Ltd., Caxton Way, Thretford, Norfolk IP24 3SE, Обединено кралство; Baxter S.A, Boulevard Rene Branquart 80, 7860 Lessines, Белгия |
21.81 |
4.36 |
26.17 |
6% |
1.31 |
23.12 |
4.62 |
27.74 |
18% |
3.93 |
27.05 |
5.41 |
32.46 |
промяна в обстоятелства НСР-5054/18.11.2014 |
КЦРР-1889/15.12.2012 г |
02.01.2013 |
02.01.2013 |
Неактивен |
3784 |
| Electrolytes |
II-13809/ 11.07.2006 |
Ringer`s injection Bieffe, Solution for infusion, 0.33 g/ 0.3 g/ 8.6 g/l - 250 ml, ml, Pack: 30 |
Baxter d.o.o., Словения |
Bieffe Medital S.p.A. |
39.59 |
7.92 |
47.51 |
4% |
1.58 |
41.17 |
8.23 |
49.4 |
16% |
6.33 |
47.5 |
9.5 |
57 |
|
КЦ-950/10.06.2009; НСР-12068/21.03.2017 |
30.06.2009 |
02.05.2017 |
Заличен |
755 |
| Electrolytes |
II-13809/ 11.07.2006 |
Ringer`s injection Bieffe, Solution for infusion, 0.33 g/ 0.3 g/ 8.6 g/l - 250 ml, ml, Pack: 30 |
Baxter d.o.o., Словения |
Bieffe Medital S.p.A. |
39.59 |
7.92 |
47.51 |
4% |
1.58 |
41.17 |
8.23 |
49.4 |
16% |
6.33 |
47.5 |
9.5 |
57 |
|
КЦ-950/10.06.2009 |
30.06.2009 |
30.06.2009 |
Неактивен |
755 |
| Electrolytes |
ІІ-13649/22.06.2006 г. |
Ringer solution, Solution for infusion, 500, ml, Pack: 1 |
Fresenius Kabi Deutschland GmbH, Германия |
Fresenius Kabi Austria GmbH, Hafnerstrasse 36 A-8055 Graz, Austria; Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg v.d.H., Germany; Fresenius Kabi Italia SpA, Via Camagre, 41-43, I-37063 Isola Della Scala-Verona, Italy |
1.66 |
0.33 |
1.99 |
7% |
0.12 |
1.78 |
0.36 |
2.14 |
20% |
0.33 |
2.11 |
0.42 |
2.53 |
|
КЦ-929/28.05.2009; НСР-12067/21.03.2017 |
11.06.2009 |
02.05.2017 |
Заличен |
753 |
| Electrolytes |
ІІ-13649/22.06.2006 г. |
Ringer solution, Solution for infusion, 500, ml, Pack: 1 |
Fresenius Kabi Deutschland GmbH, Германия |
Fresenius Kabi Austria GmbH, Hafnerstrasse 36 A-8055 Graz, Austria; Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg v.d.H., Germany; Fresenius Kabi Italia SpA, Via Camagre, 41-43, I-37063 Isola Della Scala-Verona, Italy |
1.66 |
0.33 |
1.99 |
7% |
0.12 |
1.78 |
0.36 |
2.14 |
20% |
0.33 |
2.11 |
0.42 |
2.53 |
|
КЦ-929/28.05.2009 |
11.06.2009 |
11.06.2009 |
Неактивен |
753 |
| Pioglitazone |
20110728 |
Riodin, Tablet, 45, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Hemopharm GmbH, Konigsteiner Strabe 2, 61350 Bad Homburg, Германия |
54.57 |
10.91 |
65.48 |
4% |
2.18 |
56.75 |
11.35 |
68.1 |
16% |
8.73 |
65.48 |
13.1 |
78.58 |
цената се заличава с решение НСР-6861/30.07.2015 (в сила от 02.09.2015 г) |
НСР-1628/01.11.2013 |
19.11.2013 |
19.11.2013 |
Заличен |
2211 |
| Pioglitazone |
20110727 |
Riodin, Tablet, 30, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Hemopharm GmbH, Konigsteiner Strabe 2, 61350 Bad Homburg, Германия |
40.39 |
8.08 |
48.47 |
4% |
1.62 |
42.01 |
8.4 |
50.41 |
16% |
6.46 |
48.47 |
9.69 |
58.16 |
цената се заличава с решение НСР-6860/30.07.2015 (в сила от 02.09.2015 г) |
НСР-1628/01.11.2013 |
19.11.2013 |
19.11.2013 |
Заличен |
2210 |
| Pioglitazone |
20110726 |
Riodin, Tablet, 15, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Hemopharm GmbH, Konigsteiner Strabe 2, 61350 Bad Homburg, Германия |
26.4 |
5.28 |
31.68 |
6% |
1.58 |
27.98 |
5.6 |
33.58 |
18% |
4.75 |
32.73 |
6.55 |
39.28 |
цената се заличава с решение НСР-6859/30.07.2015 (в сила от 02.09.2015 г) |
НСР-1628/01.11.2013 |
19.11.2013 |
19.11.2013 |
Заличен |
2209 |
| Risperidone |
20180303 |
Risdone, Oral solution, 1 mg/ml - 100 ml, -, Pack: 1 |
Неола Фарма ЕООД, България |
Медитрайл Интернешънълс ЕООД, България |
17.27 |
3.45 |
20.72 |
6% |
1.04 |
18.31 |
3.66 |
21.97 |
18% |
3.11 |
21.42 |
4.28 |
25.7 |
|
НСР-19566/21.08.2019 |
05.09.2019 |
02.10.2019 |
Активен |
16670 |
| Risperidone |
20180303 |
Risdone, Oral solution, 1 mg/ml - 100 ml, -, Pack: 1 |
Неола Фарма ЕООД, България |
Медитрайл Интернешънълс ЕООД, България |
17.27 |
3.45 |
20.72 |
6% |
1.04 |
18.31 |
3.66 |
21.97 |
18% |
3.11 |
21.42 |
4.28 |
25.7 |
|
НСР-19566/21.08.2019 |
05.09.2019 |
02.10.2019 |
Неактивен |
16670 |
| Risedronate |
№ II 9782/04.06.2010 |
Risendros 35 mg, Film coated tablet, 35, mg, Pack: 4 |
Zentiva k.s., Чешка република |
Zentiva k.s. - Чешка република |
4.26 |
0.85 |
5.11 |
7% |
0.3 |
4.56 |
0.91 |
5.47 |
20% |
0.85 |
5.41 |
1.08 |
6.49 |
цената е заличена с Решение НСР-5555/29.01.2015 (в сила от 16.02.2015 ) |
КЦРР-2216/06.02.2013 |
14.03.2013 |
14.03.2013 |
Заличен |
1199 |
| Risedronate |
№ II 9782/04.06.2010 |
Risendros 35 mg, Film coated tablet, 35, mg, Pack: 4 |
Zentiva k.s., Чешка република |
Zentiva k.s.U Kabelovny 130, Dolni Mecholupy 102 37 Pradue 10, Чешка република Zentiva a.s. Nitrinska 100 920 27 Hlohovec, Словакия |
13.1 |
2.62 |
15.72 |
6% |
0.79 |
13.89 |
2.78 |
16.67 |
18% |
2.36 |
16.25 |
3.25 |
19.5 |
издадена корекционна КЦ-2239/20.05.2011 |
КЦ-2175/21.04.2011 |
10.05.2011 |
10.05.2011 |
Неактивен |
1199 |
| Risperidone |
II-1937/16,04,2008 |
RISPOLEPT CONSTA 25 MG, Powder and solvent for prolonged release suspension for injection, 25, mg, Pack: 1 |
Johnson & Johnson d.o.o., Словения |
Janssen Pharmaceutica N.V., Belgium |
170.22 |
34.04 |
204.26 |
4% |
6.81 |
177.03 |
35.41 |
212.44 |
16% |
25 |
202.03 |
40.41 |
242.44 |
цената се заличава КЦРР-1361/05.09.2012 |
КЦ-380/07.01.2009 |
27.01.2009 |
27.01.2009 |
Заличен |
406 |
| Risperidone |
II-1935/16.04.2008 |
RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 |
Johnson & Johnson d.o.o., Словения |
Janssen Pharmaceutica N.V., Belgium |
187.56 |
37.51 |
225.07 |
4% |
7.5 |
195.06 |
39.01 |
234.07 |
16% |
25 |
220.06 |
44.01 |
264.07 |
|
НСР-8046/12.02.2016.; НСР-13238/17.07.2017 |
27.02.2016 |
02.11.2017 |
Заличен |
3342 |
| Risperidone |
II-1935/16.04.2008 |
RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 |
Johnson & Johnson d.o.o., Словения |
Janssen Pharmaceutica N.V., Belgium |
187.56 |
37.51 |
225.07 |
4% |
7.5 |
195.06 |
39.01 |
234.07 |
16% |
25 |
220.06 |
44.01 |
264.07 |
|
НСР-8046/12.02.2016. |
27.02.2016 |
27.02.2016 |
Неактивен |
3342 |
| Risperidone |
II-1935/16.04.2008 |
RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 |
Johnson & Johnson d.o.o., Словения |
Janssen Pharmaceutica N.V., Belgium |
187.62 |
37.52 |
225.14 |
4% |
7.5 |
195.12 |
39.02 |
234.14 |
16% |
25 |
220.12 |
44.02 |
264.14 |
|
НСР-5004/05.11.2014 |
19.11.2014 |
19.11.2014 |
Неактивен |
3342 |
| Risperidone |
II-1935/16.04.2008 |
RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 |
Johnson & Johnson d.o.o., Словения |
Janssen Pharmaceutica N.V., Belgium |
195.66 |
39.13 |
234.79 |
4% |
7.83 |
203.49 |
40.7 |
244.19 |
16% |
25 |
228.49 |
45.7 |
274.19 |
|
НСР-2424/21.01.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
3342 |
| Risperidone |
II-1935/16.04.2008 |
RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 |
Johnson & Johnson d.o.o., Словения |
Janssen Pharmaceutica N.V., Belgium |
200.49 |
40.1 |
240.59 |
4% |
8.02 |
208.51 |
41.7 |
250.21 |
16% |
25 |
233.51 |
46.7 |
280.21 |
|
КЦРР-2804/20.03.2013 |
21.05.2013 |
21.05.2013 |
Неактивен |
3342 |
| Risperidone |
II-1935/16,04,2008 |
RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 |
Johnson & Johnson d.o.o., Словения |
Janssen Pharmaceutica N.V., Belgium |
221.28 |
44.26 |
265.54 |
4% |
8.85 |
230.13 |
46.03 |
276.16 |
16% |
25 |
255.13 |
51.03 |
306.16 |
|
КЦ-380/07.01.2009 |
27.01.2009 |
27.01.2009 |
Неактивен |
3342 |
| Risperidone |
II-1936/16.04.2008 |
RISPOLEPT CONSTA 50 MG, Powder and solvent for prolonged release suspension for injection, 50, mg, Pack: 1 |
Johnson & Johnson d.o.o., Словения |
Janssen Pharmaceutica N.V., Belgium |
221.22 |
44.24 |
265.46 |
4% |
8.85 |
230.07 |
46.01 |
276.08 |
16% |
25 |
255.07 |
51.01 |
306.08 |
|
НСР-8512/16.03.2016; НСР-10674/21.10.2016; НСР-13237/17.07.2017 |
02.12.2016 |
02.11.2017 |
Заличен |
3343 |
| Risperidone |
II-1936/16.04.2008 |
RISPOLEPT CONSTA 50 MG, Powder and solvent for prolonged release suspension for injection, 50, mg, Pack: 1 |
Johnson & Johnson d.o.o., Словения |
Janssen Pharmaceutica N.V., Belgium |
221.22 |
44.24 |
265.46 |
4% |
8.85 |
230.07 |
46.01 |
276.08 |
16% |
25 |
255.07 |
51.01 |
306.08 |
|
НСР-8512/16.03.2016; НСР-10674/21.10.2016 |
02.12.2016 |
02.12.2016 |
Неактивен |
3343 |